Anthrax AV7909 Boost Evaluation Study

NCT05997264 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

220

Enrollment

FED

Sponsor class

Conditions

Anthrax

Interventions

BIOLOGICAL: AV7909 Full Dose (0.5 mL)
BIOLOGICAL: AV7909 Half Dose (0.25 mL)
BIOLOGICAL: Placebo: Sodium Chloride Injection, USP 0.9% (0.5 mL)
BIOLOGICAL: Placebo: Sodium Chloride Injection, USP 0.9% (0.25 mL)

Sponsor

Biomedical Advanced Research and Development Authority

Collaborators

[object Object]
[object Object]